Cognition Therapeutics, Inc. Share Price
Equities
CGTX
US19243B1026
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.91 USD | -1.04% | -4.50% | +3.24% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 76.47M 6.13B |
---|---|---|---|---|---|
Net income 2024 * | -39M -3.12B | Net income 2025 * | -64M -5.13B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.96
x | P/E ratio 2025 * |
-1.37
x | Employees | 27 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.45% |
Latest transcript on Cognition Therapeutics, Inc.
1 day | -1.04% | ||
1 week | -4.50% | ||
1 month | +4.95% | ||
3 months | -15.86% | ||
6 months | +70.54% | ||
Current year | +3.24% |
Managers | Title | Age | Since |
---|---|---|---|
Lisa Ricciardi
CEO | Chief Executive Officer | 64 | 28/02/19 |
John Doyle
DFI | Director of Finance/CFO | 46 | 30/04/23 |
Paul J. Tiseo
CTO | Chief Tech/Sci/R&D Officer | - | 10/10/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lisa Ricciardi
CEO | Chief Executive Officer | 64 | 28/02/19 |
Brett Monia
BRD | Director/Board Member | 62 | 30/09/20 |
Ellen Richstone
BRD | Director/Board Member | 72 | 31/10/21 |
Date | Price | Change | Volume |
---|---|---|---|
30/04/24 | 1.91 | -1.04% | 38,593 |
29/04/24 | 1.93 | -1.03% | 96,957 |
26/04/24 | 1.95 | +1.04% | 55,056 |
25/04/24 | 1.93 | -3.02% | 133,328 |
24/04/24 | 1.99 | -0.50% | 114,823 |
Delayed Quote Nasdaq, April 30, 2024 at 09:30 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.24% | 76.47M | |
-3.46% | 102B | |
+1.41% | 96.09B | |
+2.13% | 22.28B | |
-15.84% | 21.4B | |
-10.19% | 18.14B | |
-39.98% | 17.02B | |
-14.65% | 16.09B | |
+4.39% | 13.83B | |
+31.35% | 11.97B |
- Stock Market
- Equities
- CGTX Stock